Neuralink
Neuralink develops implantable brain-computer interfaces and the surgical robot used to place them, with human clinical trials underway.
The Company
Neuralink was co-founded in 2016 by Elon Musk and a group of scientists and engineers. It builds a small implant that records brain activity and a robot that places its thin electrode threads, with the first aim of letting people with paralysis control computers and phones.
In June 2025 Neuralink raised a $650 million Series E at a reported $9 billion pre-money valuation, to expand patient access to its device and develop new applications. It remains in clinical trials, with no approved commercial product.
Why It Matters
Neuralink is the most prominent private brain-computer interface company, and a read-through for how investors value medical technology that is still in clinical trials.
Valuation History
- $9B→Jun 2025$650M Series E, reported pre-money
What Changed
Neuralink is founded.
The first human patient receives a Neuralink implant.
A $650M Series E values it at a reported $9B pre-money.
THE NEXT COMPANY. A CLEARER PICTURE.
Get the next breakdown.
Independent company research and perspectives on private markets, delivered through The Private Ledger on Substack.